Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Free Cash Flow (2022 - 2025)

Historic Free Cash Flow for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$6.5 million.

  • CervoMed's Free Cash Flow fell 3317.73% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 12621.49%. This contributed to the annual value of -$16.5 million for FY2024, which is 12189.49% down from last year.
  • CervoMed's Free Cash Flow amounted to -$6.5 million in Q3 2025, which was down 3317.73% from -$6.5 million recorded in Q2 2025.
  • Over the past 5 years, CervoMed's Free Cash Flow peaked at $6.9 million during Q3 2022, and registered a low of -$8.1 million during Q4 2024.
  • Its 4-year average for Free Cash Flow is -$2.9 million, with a median of -$2.5 million in 2023.
  • The largest annual percentage gain for CervoMed's Free Cash Flow in the last 5 years was 6866.81% (2023), contrasted with its biggest fall of 26654.79% (2023).
  • Over the past 4 years, CervoMed's Free Cash Flow (Quarter) stood at -$692530.0 in 2022, then tumbled by 266.55% to -$2.5 million in 2023, then tumbled by 217.16% to -$8.1 million in 2024, then increased by 19.7% to -$6.5 million in 2025.
  • Its Free Cash Flow was -$6.5 million in Q3 2025, compared to -$6.5 million in Q2 2025 and -$3.9 million in Q1 2025.